Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Geron Receives Milestone Payment From Exeter Life Sciences
May 3rd, 2008
Geron Corporation (Nasdaq:GERN) announced that is has received a milestone payment of $1.5 million from Exeter Life Sciences, Inc. as a result of the final Risk Assessment released by the U.S. Food and Drug Administration addressing food products made from cloned animals or their progeny. The Risk Assessment, available at http://www.fda.gov/cvm/CloneRiskAssessment_Final.htm, concluded that consumption of such food products poses no greater risk than consumption of food products from animals produced by conventional breeding methods. In April 2005, Geron and Exeter Life Sciences created a joint venture company, Start Licensing, Inc., ("Start") to manage and license a...
Source: Law & Health Weekly (2008-05-03)
|
